As pointed out by Hoffmann et al., increased MDR1 gene expression was tied to a poor prognosis following cisplatin as adjuvant chemotherapy in locally advanced bladder cancer, and this data might be utilized to better tackle resistance in MDR1-highly expressed patients [85]. This evidence concerns the gene ABCB1 and urinary bladder cancer.